title: Inducing thyrotoxicosis in the liver to treat raised cholesterol.
authors.affiliation: Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5B7, Canada.
authors.forename: Robina
authors.initials: R
authors.lastname: Rana
authors.affiliation: Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5B7, Canada. Electronic address: hegele@robarts.ca.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Hegele
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D008078:Cholesterol, LDL / Q000187:drug effects*; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects*; D008297:Male
chemical_list: C526273:3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid; D000813:Anilides; D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL